Reducing orofacial pain and improving function with low-temperature plasma radiofrequency ablation

Takeaway

  • Percutaneous low-temperature plasma radiofrequency ablation (LTP-RFA) was noninferior to radiofrequency thermocoagulation (RFT) treatment for pain relief in patients with idiopathic trigeminal neuralgia, and produced significantly greater improvements in masticatory function at discharge and 6-months later.

Why this matters

  • Idiopathic trigeminal neuralgia is a common cause of intense orofacial pain. Percutaneous RFT has been proven to be an effective treatment, but complications such as facial numbness, have also been associated with RFT.

  • LTP-RFA has been proven effective in the treatment of phantom limb pain, and may reduce thermal damage to the surrounding nerve tissue compared with RFT.

  • This study demonstrated LTP-RFA was non-inferior to RFT for the pain relief and may provide a safer alternative for the management of orofacial pain in patients with idiopathic trigeminal neuralgia.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.